Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer

Tyrosine kinase inhibitors (TKIs) which target angiogenesis are promising treatments for patients with metastatic medullary and differentiated thyroid cancers. Sorafenib, sunitinib, and pazopanib are commercially available drugs which have been studied in these diseases. Vandetanib is the first drug...

Full description

Saved in:
Bibliographic Details
Main Authors: Cabanillas, Maria E., Hu, Mimi I., Durand, Jean-Bernard, Busaidy, Naifa L.
Format: Artigo
Language:Inglês
Published: SAGE-Hindawi Access to Research 2011
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3189619/
https://ncbi.nlm.nih.gov/pubmed/22007339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/985780
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items